AME

Business profile & competitive position

AMETEK, Inc. is classified in the Industrials sector under Electrical Equipment & Parts. The company’s business is built around two segments. Electronic Instruments Group (EIG) designs and manufactures advanced analytical, test and measurement instruments for process, aerospace, power and industrial markets. Electromechanical Group (EMG) supplies precision motion control solutions, highly engineered medical components and devices, thermal management systems, specialty metals and electrical interconnects to aerospace and defense, medical, automation and other industrial markets. That combination links AMETEK to capital-intensive, engineering-driven end markets where product precision and reliability tend to matter more than commodity pricing.

The latest reported margin and return figures are consistent with a business that can translate sales into profits reasonably well. Net margin is 20.0% and return on equity is 14.5%. Those levels suggest management can convert revenue into bottom-line earnings and deploy shareholder capital at returns above many broad industrial benchmarks, though the numbers alone do not prove any durable competitive moat. Given that 52% of EIG net sales and 42% of EMG net sales were to customers outside the United States in 2025, AMETEK also operates with meaningful geographic diversification rather than a single-region footprint.

Financial posture

At the current snapshot, AMETEK carries a market capitalization of $57.7 billion and trades at a price-to-earnings ratio of 36.7. The P/E is toward the upper end of what is common for large-cap industrial names, meaning the equity is priced with a meaningful growth premium built in. Net margin of 20.0% and ROE of 14.5% support the idea that the company is highly profitable, while a beta of 0.99 indicates the stock has historically moved roughly in line with the overall market, not as a defensive low-volatility name nor as a hyper-cyclical play.

Balance sheet activity in 2025 was dominated by deployment of capital. AMETEK spent $933.2 million in cash, net of cash acquired, to buy Kern and FARO Technologies. Those deals are additive to the 15 acquisitions completed from 2021 through December 31, 2025, which together contributed approximately $1.8 billion in annualized sales. That acquisition record highlights an active roll-up posture rather than a balance sheet built mainly on organic reinvestment.

Strategic priorities & outlook

AMETEK’s most recent 10-K frames the company’s strategy around the AMETEK Growth Model. The stated targets are high-single-digit annual sales growth, double-digit annual EPS growth, strong cash flow generation and a superior return on total capital. Those objectives are paired with Operational Excellence initiatives including lean manufacturing, global sourcing, Design for Six Sigma, Value Engineering/Value Analysis, growth kaizens, digitalization and artificial intelligence.

Acquisitions remain central to execution. AMETEK says it pursues strategic deals with compelling strategic, technical and cultural fit in adjacent or complementary markets aligned with secular growth themes. The 2025 additions of Kern, focused on high-precision machining and optical inspection solutions, and FARO Technologies, focused on 3D measurement and imaging solutions, fit that description. Geographic expansion is also emphasized, with best-cost manufacturing facilities in China, Czechia, Malaysia, Mexico and Serbia intended to keep production close to customers and support international growth.

Operationally, 2025 was a record year. Sales reached $7,401.1 million, up 6.6% from 2024. Diluted earnings per share were $6.40, up 7.9%. The company also reported record operating income, net income, orders and backlog, and employed approximately 22,500 people as of December 31, 2025.

Macro & geopolitical exposure

Because AMETEK sits in Electrical Equipment & Parts, its macro exposure follows the contours of that industrial niche. Demand is tied to capital spending in aerospace, defense, medical devices, factory automation, power and process industries. That means revenue can be sensitive to industrial production trends, defense budgets, healthcare capital expenditure cycles and commercial aerospace build rates.

The sector also carries typical supply-chain and trade-policy risks. Precision instruments and electromechanical components frequently use specialty metals, semiconductors and engineered materials sourced globally, so tariffs, export controls or logistics disruptions can affect costs and lead times. Currency movements matter as well, since exports and foreign manufacturing generate translation impacts. Finally, defense and aerospace work can involve regulatory, ITAR and contract-award timing dynamics that are difficult to forecast quarter to quarter.

Recent developments

Recent headlines have touched on both analyst sentiment and valuation debate. On October 1, 2026, zacks.com reported a rating upgrade to Buy. On September 17, 2026, fool.com linked NASA’s new Moon base contract opportunity to AMETEK as an under-the-radar nuclear power stock, tying the company’s aerospace and defense exposure to a major government program. On September 16, 2026, gurufocus.com published a DCF-based view that AMETEK was worth $158, well below the then-current price. On September 4, 2026, seekingalpha.com noted AMETEK among the holdings discussed in Baron SMID Cap ETF’s Q2 2026 portfolio activity. None of these items changes the underlying business, but together they show the stock is currently receiving both bullish upgrades and valuation skepticism.

Earnings behavior & post-earnings drift

AMETEK has a strong recent track record against estimates. Over the last eight reported quarters, the company beat consensus EPS in all eight, a 100% beat rate, with an average earnings surprise of 4%. However, the price reaction has not always followed the beat. The average 5-trading-day move after earnings across those quarters was 0.46%, which is classified as flat post-earnings drift.

The last four quarters illustrate that pattern clearly. On August 4, 2026, AMETEK reported EPS of $2.09 versus an estimate of $1.99, a 5.0% surprise, and the stock rose 0.28% the next day and 0.89% over the following five days. On April 30, 2026, EPS of $1.97 beat the $1.90 estimate by 3.7%, yet the stock fell 2.13% the next day and 0.33% over five days. On February 3, 2026, EPS of $2.01 beat the $1.94 estimate by 3.6%, with the stock down 0.48% the next day but up 1.83% over the next five days. On October 30, 2025, EPS of $1.89 beat the $1.76 estimate by 7.4%, producing a 1.91% next-day gain but a minus 0.54% five-day drift. The next scheduled report is October 29, 2026, before the open, with a consensus EPS estimate of $2.10. As of the latest snapshot, the price was $251.93, the RSI was 62.2 and the 50-day EMA was $242.22.

For a deeper dive into how these fundamentals, technical levels and institutional expectations intersect ahead of the October 29, 2026 earnings release, review the full institutional verdict on the stock.